Investigators analyzed IBD subtypes and their associated risks of radical prostatectomy complications among a cohort of patients with prostate cancer to fill a knowledge gap.

In this study, researchers sought to determine whether Medicaid expansion led to improvements in survival for patients with resectable NSCLC.

In this study, researchers investigated long-term outcomes from a real-world cohort of patients with stage IV melanoma treated with pembrolizumab following progression on prior therapies.

Lymphir is supplied as a 300mcg lyophilized cake in a single-dose vial for reconstitution and further dilution.

FZOCUS-1 assessed the safety and efficacy of fuzuloparib alone and in combination with apatinib for patients with newly diagnosed or advanced ovarian cancer.

Investigators sought to examine the connection between a diagnosis of cancer within 12 months following a diagnosis of hiccups ...

When cancer subtypes were examined, the analysis revealed that phototherapy was linked to a 40% increased odds of blood cancers. More modest associations were observed for solid organ cancers and ...

Five-year survival for all pediatric cancers increased from 63 percent in mid-1970s to 87 percent in 2015 to 2021.

In order to understand how patients are affected by receiving notification of their breast density, Australian researchers conducted a randomized, multi-arm trial of 2401 women with dense breasts.

Median progression-free survival was 22 months, overall survival was 152 months among patients with newly diagnosed MM.

Researchers reported on patient acceptance of an e-consent tool for asynchronous delivery of study information and for receiving consent from patients.

PRRT retreatment may be well tolerated and confer a survival benefit in patients with well-differentiated, metastatic neuroendocrine tumors, a study suggests.